Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Capital Expenditures (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Capital Expenditures readings, the most recent being $86.0 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 43.42% to $86.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $416.0 million, a 177.33% increase, with the full-year FY2025 number at $482.0 million, up 237.06% from a year prior.
  • Capital Expenditures hit $86.0 million in Q1 2026 for GE HealthCare Technologies, down from $134.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $258.0 million in Q3 2025 to a low of -$156.0 million in Q4 2024.
  • Median Capital Expenditures over the past 5 years was $86.0 million (2026), compared with a mean of $82.8 million.
  • Biggest five-year swings in Capital Expenditures: crashed 265.96% in 2024 and later skyrocketed 186.67% in 2025.
  • GE HealthCare Technologies' Capital Expenditures stood at $77.0 million in 2022, then increased by 22.08% to $94.0 million in 2023, then crashed by 265.96% to -$156.0 million in 2024, then surged by 185.9% to $134.0 million in 2025, then tumbled by 35.82% to $86.0 million in 2026.
  • The last three reported values for Capital Expenditures were $86.0 million (Q1 2026), $134.0 million (Q4 2025), and $258.0 million (Q3 2025) per Business Quant data.